http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-113291-C2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
filingDate 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-113291-C2
titleOfInvention TRANSCLOMYPHENE METABOLITES AND THEIR APPLICATIONS
abstract The present invention relates to substantially pure metabolites of transclomiphene. The invention also relates to pharmaceutical compositions containing these metabolites and their use for the treatment of disorders including secondary hypogonadism, type 2 diabetes, elevated cholesterol, increased triglycerides, depletion, lipodystrophy, female and male infertility, benign hyperthyrophyrophyrophyrosis , breast cancer, ovarian cancer and endometrial cancer.
priorityDate 2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548953

Total number of triples: 22.